CEL p.Ala601fs
c.1801del · VCV3893039
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Consequence | frameshift | predicted loss-of-function |
|---|---|---|
| NMD | escapes | premature termination codon in the last exon (11 of 11) — the truncated protein is likely expressed. PVS1 input, not an applied code |
| Splicing | ||
| SpliceAI | — | not assessed · substitutions only |
| Constraint at this position | ||
| Conservation | phyloP -20 | GERP -1.4 |
| Overall | ||
| CADD | 20.7 | PHRED · no single calibrated threshold — expert panels disagree |
| Region caveats | ||
| Repeat context | tandem | chr9:133080625 segmental duplication, simple repeat · ambiguous alignment · reads may not map uniquely · confidence, not pathogenicity |
Predicted loss-of-function is descriptive, not an applied PVS1 code.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.494% | 202 |
| Middle Eastern | 0.474% | 211 |
| Ashkenazi Jewishnot grpmax-eligible | 0.306% | 327 |
| Amishnot grpmax-eligible | 0.244% | 410 |
| Remaining individualsnot grpmax-eligible | 0.177% | 564 |
| Finnishnot grpmax-eligible | 0.115% | 871 |
| European (non-Finnish) | 0.0934% | 1,071 |
| Admixed American | 0.0209% | 4,777 |
| African / African-American | 0.0115% | 8,683 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CEL
- Protein
- p.Ala601fs
- Coding
- c.1801del
- MANE Select
- NM_001807
- Type
- Deletion
- Location
- chr9:133071300 (GRCh38)
- Gene constraint
- LOEUF 0.972 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 84.10 · 7 PDB
- Residue 601
- the 'disordered' region; the '17 x 11 aa tandem repeats, glycodomain, o-linked (mucin type)' region
Disease context
maturity-onset diabetes of the young type 8 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor MODY (Orphanet):
- Inheritance
- Autosomal dominant, Not applicable
- Onset
- Adolescent, Adult, Childhood
- Prevalence
- 1-5 / 10 000 (Europe)
Similar variants
- CEL p.Val593fs Likely pathogenic ★★ same condition
- CEL p.Ala601Pro Likely benign ★★ same residue
- CEL p.Val626fs Likely pathogenic ★ same condition
- CEL p.557ATPVPPTGDSE[1] Uncertain significance ★ same condition
- CEL p.Ala601Gly Uncertain significance ★ same residue
- CEL p.Ala733_Lys743del Uncertain significance ★ same condition
- CEL p.Asp719fs Uncertain significance ★ same condition
- CEL p.Gly166fs Uncertain significance ★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cel-p-ala601fs (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown